Shree Ganesh Bio-Tech Intrinsic Value
SHREEGANES Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹1.52 | ₹1.37 - ₹1.67 | +149.2% | Book Value/Share: ₹15.75, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹1.22 | ₹1.10 - ₹1.34 | +100.0% | Revenue/Share: ₹2.00, P/S: 2.0x |
| Simple DCF (5Y) | dcf | ₹1.52 | ₹1.22 - ₹1.82 | +149.2% | CF Growth: 15.0%, Discount: 15% |
Want to compare with current market value? Check SHREEGANES share price latest .
Valuation Comparison Chart
SHREEGANES Intrinsic Value Analysis
What is the intrinsic value of SHREEGANES?
Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Shree Ganesh Bio-Tech (SHREEGANES) is ₹1.52 (median value). With the current market price of ₹0.61, this represents a +149.2% variance from our estimated fair value.
The valuation range spans from ₹1.22 to ₹1.52, indicating ₹1.22 - ₹1.52.
Is SHREEGANES undervalued or overvalued?
Based on our multi-method analysis, Shree Ganesh Bio-Tech (SHREEGANES) appears to be trading below calculated value by approximately 149.2%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Operating Margin | -28.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.12x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
Related Pages for Shree Ganesh Bio-Tech
Additional stock information and data for SHREEGANES
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-10 Cr | ₹-10 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹10 Cr | ₹5 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹11 Cr | ₹6 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹4 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹2 Cr | ₹1 Cr | Positive Free Cash Flow | 7/10 |